Evidence map›Paper›PMID 34201982›Full record

ReviewMolecules (Basel, Switzerland)2021

Hemorphins-From Discovery to Functions and Pharmacology.

Przemyslaw Mielczarek, Kinga Hartman, Anna Drabik, Hao-Yuan Hung, Eagle Yi-Kung Huang, Ewa Gibula-Tarlowska, Jolanta H Kotlinska, Jerzy Silberring

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Computational Modeling of the Interactions between DPP IV and Hemorphins.International journal of molecular sciences · 2024
    Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Przemyslaw MielczarekFaculty of Materials Science and Ceramics, AGH University of Science and Technology, 30-059 Krakow, Poland.ORCID 0000-0003-2759-2571
Kinga HartmanFaculty of Materials Science and Ceramics, AGH University of Science and Technology, 30-059 Krakow, Poland.
Anna DrabikFaculty of Materials Science and Ceramics, AGH University of Science and Technology, 30-059 Krakow, Poland.
Hao-Yuan HungDepartment of Pharmacology, National Defense Medical Center, Taipei 11490, Taiwan.
Eagle Yi-Kung HuangDepartment of Pharmacology, National Defense Medical Center, Taipei 11490, Taiwan.
Ewa Gibula-TarlowskaDepartment of Pharmacology and Pharmacodynamics, Faculty of Pharmacy with Division of Medical Analytics, Medical University of Lublin, 20-093 Lublin, Poland.
Jolanta H KotlinskaDepartment of Pharmacology and Pharmacodynamics, Faculty of Pharmacy with Division of Medical Analytics, Medical University of Lublin, 20-093 Lublin, Poland.ORCID 0000-0002-4178-1515
Jerzy SilberringFaculty of Materials Science and Ceramics, AGH University of Science and Technology, 30-059 Krakow, Poland.
AGH University of Krakow · PLMedical University of Lublin · PLMaj Institute of Pharmacology · PLNational Defense Medical Center · TWTri-Service General Hospital · TW

Funding

Ministerstwo Nauki i Szkolnictwa Wyższego the subsidy no 16.16.160.557the Polish-Taiwanese grant HEMO PL-TW/V/2017/17
6 · The paper itself

Abstract

During the last three decades, a variety of different studies on bioactive peptides that are opioid receptor ligands, have been carried out, with regard to their isolation and identification, as well as their molecular functions in living organisms. Thus, in this review, we would like to summarize the present state-of-the art concerning hemorphins, methodological aspects of their identification, and their potential role as therapeutic agents. We have collected and discussed articles describing hemorphins, from their discovery up until now, thus presenting a very wide spectrum of their characteristic and applications. One of the major assets of the present paper is a combination of analytical and pharmacological aspects of peptides described by a team who participated in the initial research on hemorphins. This review is, in part, focused on the analysis of endogenous opioid peptides in biological samples using advanced techniques, description of the identification of synthetic/endogenous hemorphins, their involvement in pharmacology, learning, pain and other function. Finally, the part regarding hemorphin analogues and their synthesis, has been added.

Indexed as

AnimalsHumansOpioid PeptidesPainPeptide FragmentsReceptors, OpioidOpioid PeptidesPeptide FragmentsReceptors, Opioidalcoholanalysishemoglobinhemorphinsidentificationmass spectrometryopioidspainproteolytic enzymesreceptorssequencing

Identifiers

PMID34201982
PMCPMC8270332
OpenAlexW3176962054

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.